These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Expansion of Human iPSC-Derived Ureteric Bud Organoids with Repeated Branching Potential. Mae SI; Ryosaka M; Sakamoto S; Matsuse K; Nozaki A; Igami M; Kabai R; Watanabe A; Osafune K Cell Rep; 2020 Jul; 32(4):107963. PubMed ID: 32726627 [TBL] [Abstract][Full Text] [Related]
43. Profiling of miRNAs and target genes related to cystogenesis in ADPKD mouse models. Woo YM; Kim DY; Koo NJ; Kim YM; Lee S; Ko JY; Shin Y; Kim BH; Mun H; Choi S; Lee EJ; Shin JO; Park EY; Bok J; Park JH Sci Rep; 2017 Oct; 7(1):14151. PubMed ID: 29074972 [TBL] [Abstract][Full Text] [Related]
44. Cyst expansion and regression in a mouse model of polycystic kidney disease. Happé H; van der Wal AM; Salvatori DC; Leonhard WN; Breuning MH; de Heer E; Peters DJ Kidney Int; 2013 Jun; 83(6):1099-108. PubMed ID: 23466997 [TBL] [Abstract][Full Text] [Related]
45. Triptolide reduces cyst formation in a neonatal to adult transition Pkd1 model of ADPKD. Leuenroth SJ; Bencivenga N; Chahboune H; Hyder F; Crews CM Nephrol Dial Transplant; 2010 Jul; 25(7):2187-94. PubMed ID: 20139063 [TBL] [Abstract][Full Text] [Related]
46. Induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient carrying a PKD1 Q533X mutation. Lee JJ; Ho MC; Huang CY; Wen CH; Cheng YC; Hsu YH; Hwang DY; Lu HE; Chen HC; Hsieh PCH Stem Cell Res; 2017 Dec; 25():83-87. PubMed ID: 29121521 [TBL] [Abstract][Full Text] [Related]
47. Deletion of Pkd1 in renal stromal cells causes defects in the renal stromal compartment and progressive cystogenesis in the kidney. Nie X; Arend LJ Lab Invest; 2017 Dec; 97(12):1427-1438. PubMed ID: 28892094 [TBL] [Abstract][Full Text] [Related]
49. Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1. Shibazaki S; Yu Z; Nishio S; Tian X; Thomson RB; Mitobe M; Louvi A; Velazquez H; Ishibe S; Cantley LG; Igarashi P; Somlo S Hum Mol Genet; 2008 Jun; 17(11):1505-16. PubMed ID: 18263604 [TBL] [Abstract][Full Text] [Related]
50. Cyclin-Dependent Kinase 1 Activity Is a Driver of Cyst Growth in Polycystic Kidney Disease. Zhang C; Balbo B; Ma M; Zhao J; Tian X; Kluger Y; Somlo S J Am Soc Nephrol; 2021 Jan; 32(1):41-51. PubMed ID: 33046531 [TBL] [Abstract][Full Text] [Related]
51. Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression. Streets AJ; Magayr TA; Huang L; Vergoz L; Rossetti S; Simms RJ; Harris PC; Peters DJ; Ong AC Am J Physiol Renal Physiol; 2017 Apr; 312(4):F577-F588. PubMed ID: 28077374 [TBL] [Abstract][Full Text] [Related]
52. Gα12 is required for renal cystogenesis induced by Pkd1 inactivation. Wu Y; Xu JX; El-Jouni W; Lu T; Li S; Wang Q; Tran M; Yu W; Wu M; Barrera IE; Bonventre JV; Zhou J; Denker BM; Kong T J Cell Sci; 2016 Oct; 129(19):3675-3684. PubMed ID: 27505895 [TBL] [Abstract][Full Text] [Related]
53. Establishment and Characterization of MUi027-A: A Novel Patient-Derived Cell Line of Polycystic Kidney Disease with Linn AK; Maneepitasut W; Tubsuwan A; Kitiyanant N; Phakdeekitcharoen B; Borwornpinyo S; Hongeng S; Phanthong P J Pers Med; 2022 May; 12(5):. PubMed ID: 35629189 [TBL] [Abstract][Full Text] [Related]
54. Kidney enlargement and multiple liver cyst formation implicate mutations in PKD1/2 in adult sporadic polycystic kidney disease. Fujimaru T; Mori T; Sekine A; Mandai S; Chiga M; Kikuchi H; Ando F; Mori Y; Nomura N; Iimori S; Naito S; Okado T; Rai T; Hoshino J; Ubara Y; Uchida S; Sohara E Clin Genet; 2018 Jul; 94(1):125-131. PubMed ID: 29520754 [TBL] [Abstract][Full Text] [Related]
55. Pkd1-targeted mutation reveals a role for the Wolffian duct in autosomal dominant polycystic kidney disease. Tee JB; Dnyanmote AV; Lorenzo MK; Lee OR; Grisaru S; Suk M; Acott PD J Dev Orig Health Dis; 2020 Feb; 11(1):78-85. PubMed ID: 31412963 [TBL] [Abstract][Full Text] [Related]
56. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model. Leonhard WN; van der Wal A; Novalic Z; Kunnen SJ; Gansevoort RT; Breuning MH; de Heer E; Peters DJ Am J Physiol Renal Physiol; 2011 May; 300(5):F1193-202. PubMed ID: 21345977 [TBL] [Abstract][Full Text] [Related]
57. Demographic and clinical characteristics of children with autosomal dominant polycystic kidney disease: a single center experience. Kasap Demir B; Mutlubaş F; Soyaltın E; Alparslan C; Arya M; Alaygut D; Arslansoyu Çamlar S; Berdeli A; Yavaşcan Ö Turk J Med Sci; 2021 Apr; 51(2):772-777. PubMed ID: 33315352 [TBL] [Abstract][Full Text] [Related]
58. Ganetespib limits ciliation and cystogenesis in autosomal-dominant polycystic kidney disease (ADPKD). Nikonova AS; Deneka AY; Kiseleva AA; Korobeynikov V; Gaponova A; Serebriiskii IG; Kopp MC; Hensley HH; Seeger-Nukpezah TN; Somlo S; Proia DA; Golemis EA FASEB J; 2018 May; 32(5):2735-2746. PubMed ID: 29401581 [TBL] [Abstract][Full Text] [Related]
59. TAZ/Wnt-β-catenin/c-MYC axis regulates cystogenesis in polycystic kidney disease. Lee EJ; Seo E; Kim JW; Nam SA; Lee JY; Jun J; Oh S; Park M; Jho EH; Yoo KH; Park JH; Kim YK Proc Natl Acad Sci U S A; 2020 Nov; 117(46):29001-29012. PubMed ID: 33122431 [TBL] [Abstract][Full Text] [Related]
60. Novel inhibitors of nuclear transport cause cell cycle arrest and decrease cyst growth in ADPKD associated with decreased CDK4 levels. Tan M; Wettersten HI; Chu K; Huso DL; Watnick T; Friedlander S; Landesman Y; Weiss RH Am J Physiol Renal Physiol; 2014 Dec; 307(11):F1179-86. PubMed ID: 25234309 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]